These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26871895)

  • 41. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genital anomalies in boys and the environment.
    Main KM; Skakkebaek NE; Virtanen HE; Toppari J
    Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):279-89. PubMed ID: 20541152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrine disrupting chemicals and their effects on the reproductive health in men.
    Thacharodi A; Hassan S; Acharya G; Vithlani A; Hoang Le Q; Pugazhendhi A
    Environ Res; 2023 Nov; 236(Pt 2):116825. PubMed ID: 37544467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germ cell cancer and disorders of spermatogenesis: an environmental connection?
    Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Carlsen E; Petersen PM; Giwercman A; Andersen AG; Jensen TK; Andersson AM; Müller J
    APMIS; 1998 Jan; 106(1):3-11; discussion 12. PubMed ID: 9524557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical correlates of environmental endocrine disruptors.
    Safe S
    Trends Endocrinol Metab; 2005; 16(4):139-44. PubMed ID: 15860409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of endogenous and exogenous hormones on testicular cancer: the epidemiological evidence.
    Giannandrea F; Paoli D; Figà-Talamanca I; Lombardo F; Lenzi A; Gandini L
    Int J Dev Biol; 2013; 57(2-4):255-63. PubMed ID: 23784836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis.
    Jørgensen N; Rajpert-De Meyts E; Main KM; Skakkebaek NE
    Int J Androl; 2010 Apr; 33(2):298-303. PubMed ID: 20132348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Features of impaired seminiferous tubule differentiation are associated with germ cell neoplasia in adult men surgically treated in childhood because of cryptorchidism.
    Gumińska A; Slowikowska-Hilczer J; Kuzański W; Sosnowski M; Oszukowska E; Marchlewska K; Walczak-Jedrzejowska R; Niedzielski J; Kula K
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S163-8. PubMed ID: 18292827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
    Giulivo M; Lopez de Alda M; Capri E; Barceló D
    Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult immunohistochemical markers fail to detect intratubular germ cell neoplasia in prepubertal boys with cryptorchidism.
    Kvist K; Clasen-Linde E; Cortes D; Petersen BL; Thorup J
    J Urol; 2014 Apr; 191(4):1084-9. PubMed ID: 24095908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent trends in male reproductive disorders].
    Iwamoto T; Nozawa S
    Nihon Rinsho; 2000 Dec; 58(12):2514-20. PubMed ID: 11187747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Country-specific chemical signatures of persistent environmental compounds in breast milk.
    Krysiak-Baltyn K; Toppari J; Skakkebaek NE; Jensen TS; Virtanen HE; Schramm KW; Shen H; Vartiainen T; Kiviranta H; Taboureau O; Brunak S; Main KM
    Int J Androl; 2010 Apr; 33(2):270-8. PubMed ID: 19780864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
    Emerson RE; Ulbright TM
    Pathology; 2010 Jun; 42(4):344-55. PubMed ID: 20438407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L1-CAM is commonly expressed in testicular germ cell tumours.
    Fankhauser CD; Bode PK; Hermanns T; Sander S; Beyer J; Sulser T; Altevogt P; Moch H; Tischler V
    J Clin Pathol; 2016 May; 69(5):460-2. PubMed ID: 26933044
    [No Abstract]   [Full Text] [Related]  

  • 55. Endocrine-disrupting chemicals and male reproductive health.
    Mínguez-Alarcón L; Gaskins AJ; Meeker JD; Braun JM; Chavarro JE
    Fertil Steril; 2023 Dec; 120(6):1138-1149. PubMed ID: 37827483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates.
    Habert R; Muczynski V; Lehraiki A; Lambrot R; Lécureuil C; Levacher C; Coffigny H; Pairault C; Moison D; Frydman R; Rouiller-Fabre V
    Folia Histochem Cytobiol; 2009; 47(5):S67-74. PubMed ID: 20067897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testicular dysgenesis syndrome: possible role of endocrine disrupters.
    Bay K; Asklund C; Skakkebaek NE; Andersson AM
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations.
    Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Main KM; Leffers H; Andersson AM; Juul A; Jensen TK; Toppari J
    Int J Androl; 2007 Aug; 30(4):198-204; discussion 204-5. PubMed ID: 17705804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocrine disruptors and male reproductive function--a short review.
    Chia SE
    Int J Androl; 2000; 23 Suppl 2():45-6. PubMed ID: 10849494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
    Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.